(secondQuint)ABSORB II Randomized Controlled Trial.

 In the USA, ABSORB BVS is currently in development at Abbott Vascular.

 Not available for sale in the US.

.

 ABSORB II Randomized Controlled Trial@highlight

Prospective, randomized (2:1), active control, single blinded, parallel two-arm, multi-center clinical investigation using Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System (ABSORB BVS); compared to Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System (XIENCE)